| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,041 | 1,662 | 2,026 | 1,768 | | Cost of Revenue | 1,212 | 621 | 712 | 437 | | | Gross Profit | 829 | 1,041 | 1,315 | 1,331 | | | Operating Expenses | | Research Development | 2,005 | 1,745 | 2,207 | 1,956 | | Selling General and Administrative | 1,436 | 1,358 | 1,648 | 1,978 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,612) | (2,062) | (2,540) | (2,603) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11) | (27) | (2) | 84 | | Earnings Before Interest And Taxes | (2,624) | (2,089) | (2,541) | (2,519) | | Interest Expense | 270 | 165 | 195 | 224 | | Income Before Tax | (2,894) | (2,254) | (2,737) | (2,743) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,894) | (2,254) | (2,737) | (2,743) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,894) | (2,254) | (2,737) | (2,743) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,894) | ($2,254) | ($2,737) | ($2,743) |
|
0.83% Nasdaq 0.00%
Income Statement
